
Insulin efsitora alfa-gobe (Onswik; Eli Lilly and Company) is designed to deliver steady basal insulin levels over a full 7-day duration.
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses potential barriers to inhaled insulin, like Afrezza.
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses potential barriers to inhaled insulin, like Afrezza.
This video was filmed at CHPC 2015.






